Who owns BIOMARIN PHARMACEUTICAL?
- CUSIP Number: 09061gak7
Tip: Access positions for across all investors
Analyze quarterly positions in Biomarin Pharmaceutical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biomarin Pharmaceutical stock
Who bought or sold BIOMARIN PHARMACEUTICAL this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tenor Capital Management | 102M | $98M | 32% | Sep 2025 |
|
| Ing Investment Management | 70M | $66M | 0% | Sep 2025 |
|
| BlackRock | 38M | $36M | 0% | Sep 2025 |
|
| MacKay Shields | 35M | $34M | -21% | Sep 2025 |
|
| Opti Capital Management | 32M | $31B | 100% | Sep 2025 |
|
| Capstone Investment Advisors | 30M | $29M | 140% | Sep 2025 |
|
| Wellesley Investment Advisors | 27M | $26B | -47% | Sep 2025 |
|
| Millennium Management | 25M | $24M | 100% | Sep 2025 |
|
| Lazard Asset Management | 24M | $228k | 48% | Sep 2025 |
|
| Oaktree Capital Management | 20M | $19M | 1231% | Sep 2025 |
|
| Victory Capital Management | 19M | $18M | -3% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 17M | $16M | -25% | Sep 2025 |
|
| Thrivent Financial for Lutherans | 16M | $15M | 10% | Sep 2025 |
|
| CNH Partners | 14M | $13M | -74% | Sep 2025 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 14M | $13M | -5% | Sep 2025 |
|
| Jpmorgan Chase & Co | 13M | $13M | 64% | Sep 2025 |
|
| State Street Corporation | 12M | $12M | 5% | Sep 2025 |
|
| Franklin Resources | 5.7M | $5.4M | -32% | Sep 2025 |
|
| Palisade Capital Management | 3.7M | $3.5M | 301% | Sep 2025 |
|
| Morgan Stanley | 3.6M | $3.4M | 100% | Jun 2025 |
|
| Russell Investments | 3.5M | $3.3M | 201% | Sep 2025 |
|
| Sonora Investment Management Group | 3.5M | $3.3M | -5% | Sep 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $2.8M | 50% | Sep 2025 |
|
| Bnp Paribas Investment Partners | 2.9M | $2.8M | 0% | Sep 2025 |
|
| Conning | 2.7M | $2.6M | 100% | Sep 2025 |
|
| Wellington Management Company | 2.6M | $2.5M | -15% | Sep 2025 |
|
| Toronto-Dominion Bank | 2.0M | $1.9M | 100% | Sep 2025 |
|
| Macquarie Group | 1.9M | $1.8M | -14% | Sep 2025 |
|
| Wells Fargo & Company | 1.6M | $1.5M | -1% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 1.2M | $1.1M | 71% | Sep 2025 |
|
| Prospector Partners | 1.0M | $948k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 549k | $521k | -83% | Sep 2025 |
|
| Barclays | 534k | $507k | 39% | Sep 2025 |
|
| Kohlberg Kravis Roberts & Co | 534k | $508k | -64% | Sep 2025 |
|
| Kornitzer Capital Management | 500k | $474k | 0% | Sep 2025 |
|
| Bank of New York Mellon | 500k | $475k | 67% | Sep 2025 |
|
| Leucadia National Corporation | 400k | $381k | 4% | Sep 2025 |
|
| Sei Investments | 371k | $352k | 0% | Sep 2025 |
|
| Oppenheimer Asset Management | 182k | $173k | 2% | Sep 2025 |
|
| Stephens | 54k | $51k | 0% | Sep 2025 |
|
| Raymond James Financial | 47k | $45k | -2% | Sep 2025 |
|
| Capital Investment Advisory Services | 43k | $41k | 0% | Sep 2025 |
|
| Steward Partners Investment Advisory | 42k | $40k | -19% | Sep 2025 |
|
| Mariner Wealth Advisors | 42k | $40k | 0% | Sep 2025 |
|
| Wiley Bros.-aintree Capital | 35k | $28k | 17% | Sep 2025 |
|
| Balboa Wealth Partners | 33k | $31k | 0% | Sep 2025 |
|
| Ameriprise Financial | 32k | $30k | 0% | Sep 2025 |
|
| Foresight Capital Management Advisors | 29k | $28k | 0% | Sep 2025 |
|
| Rsm Us Wealth Management | 28k | $27k | 0% | Sep 2025 |
|
| LPL Financial | 25k | $24k | 92% | Sep 2025 |
|
| HB Wealth Management | 11k | $11k | 0% | Sep 2025 |
|
| Fifth Third Bancorp | 11k | $1.0M | 100% | Sep 2025 |
|
| Davenport & Co | 10k | $948k | 0% | Sep 2025 |
|
| Cetera Investment Advisers | 10k | $9.5k | 0% | Sep 2025 |
|
| Brian McDonald | 9.0k | $8.5k | 0% | Sep 2025 |
|
| Us Bancorp | 5.0k | $4.7k | 0% | Sep 2025 |
|
| UBS Group | 2.0k | $1.9k | 100% | Sep 2025 |
|
| Oddo Bhf Asset Management Sas | 225.00 | $215k | 0% | Sep 2025 |
|
| Erste Asset Management GmbH | 0 | $0 | -100% | Sep 2025 |
|
Who sold out of Biomarin Pharmaceutical?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Readystate Asset Management | Jun 2025 | 20M | $19M |
| Union Bancaire Privee, UBP SA | Jun 2025 | 2.9M | $2.4M |
| American Century Companies | Jun 2025 | 455k | $430k |
| Loomis, Sayles and | Jun 2025 | 252k | $14M |
| Zurcher Kantonalbank | Jun 2025 | 200k | $187k |
| Virtus ETF Advisers | Jun 2025 | 35k | $33k |
| HPM Partners | Jun 2025 | 34k | $32k |
| Ronald Blue Trust | Jun 2025 | 18k | $17k |
| Calamos Advisors | Jun 2025 | 16k | $15k |
| Bartlett & Co. Wealth Management | Jun 2025 | 5.0k | $4.7k |
| Intellectus Partners | Jun 2025 | 289.00 | $273k |